ITPV970009A0 - Preparazione di compresse a rilascio controlato a base di complessi tra carragenano e farmaci basici solubili - Google Patents
Preparazione di compresse a rilascio controlato a base di complessi tra carragenano e farmaci basici solubiliInfo
- Publication number
- ITPV970009A0 ITPV970009A0 IT97PV000009A ITPV970009A ITPV970009A0 IT PV970009 A0 ITPV970009 A0 IT PV970009A0 IT 97PV000009 A IT97PV000009 A IT 97PV000009A IT PV970009 A ITPV970009 A IT PV970009A IT PV970009 A0 ITPV970009 A0 IT PV970009A0
- Authority
- IT
- Italy
- Prior art keywords
- carragenan
- complexes
- preparation
- controlled
- release tablets
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97PV000009A IT1297461B1 (it) | 1997-10-29 | 1997-10-29 | Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili |
| DE69813872T DE69813872T2 (de) | 1997-10-29 | 1998-10-29 | Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung |
| AT98961110T ATE238070T1 (de) | 1997-10-29 | 1998-10-29 | Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung |
| CA002307863A CA2307863A1 (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| NZ504793A NZ504793A (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| PCT/EP1998/006864 WO1999021586A2 (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| JP2000517744A JP2001521010A (ja) | 1997-10-29 | 1998-10-29 | 特異な粒度分布を有するカラギーナンと水溶性薬物の複合体および比較制御放出医薬組成物 |
| BR9813149-4A BR9813149A (pt) | 1997-10-29 | 1998-10-29 | Complexo de carragenano, processo para preparação do mesmo, composição farmacêutica de liberação controlada, e, processos pra preparar composições farmecêuticas de liberação controlada na forma de tabletes e na forma de glânulos ou na forma de pelotas |
| EP98961110A EP1030689B1 (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| KR1020007004655A KR20010031604A (ko) | 1997-10-29 | 1998-10-29 | 특정 과립크기를 갖는 카라기난과 수용성 약물의 복합물및 이와 관련된 방출제어 약학적 조성물 |
| US09/530,245 US6355272B1 (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharamaceutical compositions |
| AU16651/99A AU735337B2 (en) | 1997-10-29 | 1998-10-29 | Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| ES98961110T ES2196632T3 (es) | 1997-10-29 | 1998-10-29 | Complejo entre carragenina y un medicamento soluble en agua con una granulometria especifica y composiciones farmaceuticas de liberacion controlada relativa. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97PV000009A IT1297461B1 (it) | 1997-10-29 | 1997-10-29 | Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITPV970009A0 true ITPV970009A0 (it) | 1997-10-29 |
| ITPV970009A1 ITPV970009A1 (it) | 1999-04-29 |
| IT1297461B1 IT1297461B1 (it) | 1999-12-17 |
Family
ID=11397386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT97PV000009A IT1297461B1 (it) | 1997-10-29 | 1997-10-29 | Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6355272B1 (it) |
| EP (1) | EP1030689B1 (it) |
| JP (1) | JP2001521010A (it) |
| KR (1) | KR20010031604A (it) |
| AT (1) | ATE238070T1 (it) |
| AU (1) | AU735337B2 (it) |
| BR (1) | BR9813149A (it) |
| CA (1) | CA2307863A1 (it) |
| DE (1) | DE69813872T2 (it) |
| ES (1) | ES2196632T3 (it) |
| IT (1) | IT1297461B1 (it) |
| NZ (1) | NZ504793A (it) |
| WO (1) | WO1999021586A2 (it) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| US20030229158A1 (en) * | 2001-09-28 | 2003-12-11 | Chen Jen Chi | Polymer composition and dosage forms comprising the same |
| RU2322263C2 (ru) * | 2001-11-13 | 2008-04-20 | Астеллас Фарма, Инк. | Система продолжительного высвобождения растворимого лекарственного средства |
| FR2838349B1 (fr) * | 2002-04-15 | 2004-06-25 | Laurence Paris | Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication |
| WO2003093322A2 (en) * | 2002-04-30 | 2003-11-13 | The Population Council, Inc. | Carrageenan based antimicrobial compositions |
| US8367098B2 (en) * | 2002-04-30 | 2013-02-05 | The Population Council, Inc. | Unique combinations of antimicrobial compositions |
| SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| US20040091528A1 (en) * | 2002-11-12 | 2004-05-13 | Yamanouchi Pharma Technologies, Inc. | Soluble drug extended release system |
| CN1819821B (zh) * | 2003-08-08 | 2010-10-13 | 拜奥维尔实验室国际股份有限公司 | 盐酸安非他酮的改良释放片剂 |
| EP1768653A4 (en) * | 2004-06-25 | 2012-08-01 | Univ Texas | METHOD AND COMPOSITIONS FOR TREATING ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY AND HYPERPHENYL ALANINEMIA |
| US20050287212A1 (en) * | 2004-06-28 | 2005-12-29 | Liang-Chang Dong | Oral delivery system comprising a drug/polymer complex |
| SI2262486T1 (sl) | 2008-08-01 | 2013-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Sestavek kvetiapina |
| JP2011068606A (ja) * | 2009-09-25 | 2011-04-07 | Kumamoto Univ | 徐放性担体及び同徐放性担体を用いた薬剤並びに同薬剤を用いたドラッグデリバリーシステム |
| US9364549B2 (en) | 2011-11-30 | 2016-06-14 | Andreas Voigt | Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| US9474715B2 (en) | 2011-11-30 | 2016-10-25 | Andreas Voigt | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| US20130303632A1 (en) * | 2012-05-10 | 2013-11-14 | Fmc Corporation | Controlled release solid dose form |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5227M (it) * | 1966-03-18 | 1967-08-14 | ||
| US3558768A (en) * | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
| SE8204244L (sv) * | 1982-07-09 | 1984-01-10 | Ulf Schroder | Kristalliserad kolhydratsmatris for biologiskt aktiva substanser |
| DK171716B1 (da) * | 1982-03-12 | 1997-04-07 | Pharmacia & Upjohn Ab | Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol |
| JPS60174729A (ja) | 1984-02-21 | 1985-09-09 | Nippon Shinyaku Co Ltd | 抗癌医薬組成物 |
| US4613497A (en) | 1984-02-29 | 1986-09-23 | Health Products Development, Inc. | Dry, water-foamable pharmaceutical compositions |
| JPS61130239A (ja) | 1984-11-30 | 1986-06-18 | Dai Ichi Seiyaku Co Ltd | 複合体 |
| FR2618073B1 (fr) * | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
| SE9103110D0 (sv) | 1991-10-24 | 1991-10-24 | Kabi Pharmacia Ab | New drug formulation |
-
1997
- 1997-10-29 IT IT97PV000009A patent/IT1297461B1/it active IP Right Grant
-
1998
- 1998-10-29 AT AT98961110T patent/ATE238070T1/de not_active IP Right Cessation
- 1998-10-29 NZ NZ504793A patent/NZ504793A/en unknown
- 1998-10-29 CA CA002307863A patent/CA2307863A1/en not_active Abandoned
- 1998-10-29 ES ES98961110T patent/ES2196632T3/es not_active Expired - Lifetime
- 1998-10-29 WO PCT/EP1998/006864 patent/WO1999021586A2/en not_active Application Discontinuation
- 1998-10-29 US US09/530,245 patent/US6355272B1/en not_active Expired - Fee Related
- 1998-10-29 BR BR9813149-4A patent/BR9813149A/pt not_active IP Right Cessation
- 1998-10-29 JP JP2000517744A patent/JP2001521010A/ja active Pending
- 1998-10-29 AU AU16651/99A patent/AU735337B2/en not_active Ceased
- 1998-10-29 DE DE69813872T patent/DE69813872T2/de not_active Expired - Fee Related
- 1998-10-29 EP EP98961110A patent/EP1030689B1/en not_active Expired - Lifetime
- 1998-10-29 KR KR1020007004655A patent/KR20010031604A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1030689B1 (en) | 2003-04-23 |
| DE69813872T2 (de) | 2004-02-26 |
| KR20010031604A (ko) | 2001-04-16 |
| WO1999021586A2 (en) | 1999-05-06 |
| IT1297461B1 (it) | 1999-12-17 |
| CA2307863A1 (en) | 1999-05-06 |
| AU1665199A (en) | 1999-05-17 |
| NZ504793A (en) | 2002-03-01 |
| EP1030689A1 (en) | 2000-08-30 |
| JP2001521010A (ja) | 2001-11-06 |
| DE69813872D1 (de) | 2003-05-28 |
| BR9813149A (pt) | 2000-08-15 |
| ATE238070T1 (de) | 2003-05-15 |
| ES2196632T3 (es) | 2003-12-16 |
| AU735337B2 (en) | 2001-07-05 |
| ITPV970009A1 (it) | 1999-04-29 |
| US6355272B1 (en) | 2002-03-12 |
| WO1999021586A3 (en) | 1999-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITPV970009A0 (it) | Preparazione di compresse a rilascio controlato a base di complessi tra carragenano e farmaci basici solubili | |
| PT984773E (pt) | Formulacao farmaceutica a base de omeprazole | |
| IT1313549B1 (it) | Formulazioni farmaceutiche a base di epotilone 3 | |
| NO20014526D0 (no) | Farmasöytiske preparater omfattende metallkomplekser | |
| DE69814091D1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
| EE03337B1 (et) | Kiirestilahustuv galantamiinhüdrobromiiditablett | |
| MA26549A1 (fr) | Medicaments | |
| NO992340D0 (no) | Faste farmas°ytiske blandinger omfattende et cyklosporin og et aniomisk overflateaktivt middel | |
| EP1006998A4 (en) | TOPICAL ACTIVE SUBSTANCE PREPARATIONS | |
| IT8948369A0 (it) | Composizioni farmaceutiche a base di ciclosporine | |
| FR2643262B1 (fr) | Compositions pharmaceutiques a base de cyclosporines | |
| IS5524A (is) | Forðatöflur til inntöku | |
| FR2642650B1 (fr) | Nouvelles compositions pharmaceutiques a base de cyclosporines | |
| HUP0101040A3 (en) | Lipophilic microparticles containing a protein drug or antigen and formulation comprising same | |
| ATE432707T1 (de) | Pharmazeutische zubereitung | |
| DK0868911T3 (da) | Rapamycinpræparater til oral indgivelse | |
| NO996161L (no) | En kontrollert frigjoerende formulering for tungt loeselige basiske legemidler | |
| NO20006576D0 (no) | Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette | |
| NL194827B (nl) | Thieno-triazolo-diazepinederivaten en farmaceutische preparaten die een dergelijk derivaat bevatten. | |
| PT1037652E (pt) | Composicoes farmaceuticas a base de dalfopristina e de quinupristina e sua preparacao | |
| EE9800275A (et) | Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid | |
| PT949923E (pt) | Composicoes farmaceuticas estabilizadas a base de quinupristina e de dalfopristina e sua preparacao | |
| DE69906934D1 (de) | Arzneizubereitungen | |
| FR2814368B1 (fr) | Preparation pharmaceutique a base d'oxans | |
| IT1290792B1 (it) | Preparati a base di microcellulosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |